Qingfei Jiedu decoction inhibits PD-L1 expression in lung adenocarcinoma based on network pharmacology analysis, molecular docking and experimental verification
Objective: We aim at investigating the molecular mechanisms through which the Qingfei Jiedu decoction (QFJDD) regulates PD-L1 expression in lung adenocarcinoma (LUAD).Methods: Bioactive compounds and targets of QFJDD were screened from TCMSP, BATMAN-TCM, and literature. Then, GeneCard, OMIM, PharmGK...
Saved in:
Main Authors: | Junjie Pan (Author), Hongkuan Yang (Author), Lihong Zhu (Author), Yafang Lou (Author), Bo Jin (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the pharmacological mechanism of Xianlian Jiedu decoction in the treatment of colorectal Cancer based on network pharmacology, molecular docking and experimental validation
by: Ke Cai, et al.
Published: (2023) -
Analysis of the mechanism of Erchen decoction in treating chronic bronchitis based on network pharmacology and molecular docking
by: Yanshan HE, et al.
Published: (2021) -
Network pharmacology and molecular docking analysis on molecular targets and mechanism prediction of Huanglian Jiedu Decoction in the treatment of COVID-19
by: Xu Xinyi, et al.
Published: (2022) -
Unraveling the treatment effects of huanglian jiedu decoction on drug-induced liver injury based on network pharmacology, molecular docking and experimental validation
by: Yaochen Xie, et al.
Published: (2024) -
Research Advance on Qingfei Paidu Decoction in Prescription Principle, Mechanism Analysis and Clinical Application
by: Wei Ren, et al.
Published: (2021)